MASHINIi

Sol-Gel Technologies Ltd..

SLGL.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Sol-Gel Technologies Ltd. is a dermatology company focused on identifying, developing, and commercializing branded and generic topical products to treat skin diseases. The company utilizes its proprietary microencapsulation technology to create differentiated products. Their portfolio includes produ...Show More

Ethical Profile

Mixed.

Sol-Gel Technologies Ltd. has a mixed ethical profile. Its focus on developing dermatological drugs like Twyneo and Epsolay for conditions such as acne and rosacea inherently contributes to better health outcomes. However, the reliance on prescription medications may raise concerns about affordable access for some patients. For most other ethical considerations, including fair pay, worker respect, ethical sourcing, environmental impact, and animal welfare, there is insufficient public information to assess Sol-Gel's performance.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech0
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

Insufficient evidence to determine a value score for Sol-Gel Technologies Ltd. regarding Better Health for All. No articles or relevant information found. A neutral score of 0 is assigned. Materiality Analysis: Company Summary (75-100 words): Sol-Gel Technologies is a pharmaceutical company focused on developing and commercializing topical dermatological drugs. Their primary products, Twyneo and Epsolay, treat acne vulgaris and rosacea, respectively. They also have pipeline products targeting Gorlin Syndrome and rare hyperkeratinization disorders. The company operates in Israel, China, Switzerland, Canada, and internationally, with collaborations and licensing agreements with other pharmaceutical companies. Their business model centers on developing and marketing prescription medications for skin conditions. Peer Comparison (50-75 words): Compared to other dermatology-focused pharmaceutical companies, Sol-Gel appears to be performing at the industry standard regarding "Better Health for All." Many companies in this sector focus on developing treatments for specific conditions, which inherently contributes to improved health outcomes for affected individuals. Materiality Assessment (1-2 clear sentences): The business model is fundamentally supportive of the "Better Health for All" value, with a high level of materiality, as the company directly develops and provides treatments for skin conditions, contributing to improved patient health outcomes. Detailed Rationale (150-200 words): Sol-Gel's core business directly addresses health needs by developing and marketing prescription medications for skin conditions. These medications, such as Twyneo and Epsolay, aim to improve the health and quality of life for individuals suffering from acne vulgaris and rosacea. The company's pipeline products targeting Gorlin Syndrome and rare hyperkeratinization disorders further demonstrate a commitment to addressing unmet medical needs. While the company's focus is on specific dermatological conditions, this specialization allows for targeted research and development efforts, potentially leading to more effective treatments. The company's collaborations and licensing agreements also extend its reach and impact on patient health. The accessibility and pricing of these medications are relevant considerations, but the fundamental nature of developing and providing treatments for skin conditions aligns strongly with the "Better Health for All" value. Value Interaction Notes (if applicable, 25-50 words): The company's focus on prescription medications may create tensions with "Affordable Access," as pricing strategies could limit accessibility for some patients. Scoring Boundary Flags (if applicable, 25-50 words): Scores significantly below the median would be illogical, given the company's direct involvement in developing and providing treatments for skin conditions. A score of 1 or 2 would not be appropriate.

Fair Money & Economic Opportunity

0

No evidence available to assess Sol-Gel Technologies Ltd. on Fair Money & Economic Opportunity.

Fair Pay & Worker Respect

0

The provided articles do not contain specific, quantitative data points for any of the 'Fair Pay & Worker Respect' KPIs. explicitly states that data for living wage coverage, CEO median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, and health insurance coverage is currently not available.

1
Articles
2
,
3
,
4
, and
5
also lack any relevant information for these metrics.

Fair Trade & Ethical Sourcing

0

No relevant data was found in the provided articles to assess SLGL.US against the 'Fair Trade & Ethical Sourcing' ethical value. All articles either indicated a lack of content, a 404 error, or that the request was throttled, preventing the extraction of any specific facts, numbers, or policies related to fair trade certifications, audit frequencies, labor incidents, traceability, remediation, ethical clauses, materials risk, or supplier diversity spend.

Honest & Fair Business

-40

The company has a Whistleblower Policy that allows for anonymous and confidential reporting of accounting, internal accounting controls, fraud, or auditing matters, and it prohibits retaliation for good faith reports.

1
However, there is no evidence of independent investigation processes for these reports. The company also maintains a Code of Business Conduct and Ethics that prohibits giving anything of value to foreign government officials or political candidates to obtain or retain business, in compliance with the U.S. Foreign Corrupt Practices Act and the Israeli Penal Code.
2
All employees, officers, directors, and certain designated third-party service providers are required to sign a Certificate of Compliance.
3
Gifts and entertainment generally should not exceed $75 unless approved by the CFO.
4
However, the frequency of training and metrics for the effectiveness of this policy are not specified.

Kind to Animals

0

No specific data or quantitative metrics regarding Sol-Gel Technologies Ltd.'s performance on animal welfare, cruelty-free certifications, alternative testing methods, or any other 'Kind to Animals' KPIs were found in the provided articles.

1
The articles explicitly state that no relevant data is available for SLGL.US.
2

No War, No Weapons

0

No evidence available to assess Sol-Gel Technologies Ltd. on No War, No Weapons.

Planet-Friendly Business

0

No evidence available to assess Sol-Gel Technologies Ltd. on Planet-Friendly Business.

Respect for Cultures & Communities

0

No evidence was found in the provided articles regarding SLGL.US's performance on any of the KPIs related to the 'Respect for Cultures & Communities' ethical value. The articles either pertained to a different company (American Homes 4 Rent) or explicitly stated that no relevant data for SLGL.US was present.

1
One article was inaccessible due to throttling.
2

Safe & Smart Tech

0

No evidence available to assess Sol-Gel Technologies Ltd. on Safe & Smart Tech.

Zero Waste & Sustainable Products

0

No specific, factual evidence was found in the provided articles regarding Sol-Gel Technologies Ltd.'s (SLGL.US) performance on any of the 'Zero Waste & Sustainable Products' KPIs. The articles either contained financial information without sustainability data,

1
were inaccessible,
2
or discussed other companies or research related to 'sol-gel' technology (such as battery recycling
3
or plastic-free coatings for paper products by 'Sol-Gel Materials and Applications Ltd.')
4
that were not identified as pertaining to SLGL.US, a dermatology company.

Own Sol-Gel Technologies Ltd.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.